Janney Montgomery Scott LLC Decreases Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Janney Montgomery Scott LLC decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 4.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 521,522 shares of the pharmacy operator’s stock after selling 23,885 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Walgreens Boots Alliance were worth $13,617,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 845 shares in the last quarter. Highlander Capital Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth about $26,000. Venturi Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares in the last quarter. Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. Finally, Tyler Stone Wealth Management lifted its holdings in shares of Walgreens Boots Alliance by 1,280.0% during the third quarter. Tyler Stone Wealth Management now owns 1,380 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 1,280 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Truist Financial restated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a report on Monday, April 1st. Deutsche Bank Aktiengesellschaft dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, April 3rd. SVB Leerink lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Finally, Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $24.36.

View Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Down 0.9 %

Shares of NASDAQ WBA opened at $18.18 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $17.12 and a 1-year high of $32.89. The business’s 50 day moving average is $18.91 and its two-hundred day moving average is $21.32. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.16 earnings per share. As a group, analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.50%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.29%.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.